arthritis


ArthroCBD Shares Study’s Findings for Arthritis Awareness Month

May 24th, 2021 - Ryan Allway

BOULDER, Colo., May 24, 2021 /PRNewswire/ — Arthritis is one of the most widespread health conditions in the United States and affects one in four adults, according to the CDC. That’s over 54 million men and women. There are common misconceptions around Arthritis, including what it’s like to live with it. ArthroCBD recently performed quantitative and qualitative studies to “debunk” these myths.  […]

Ovation Science Takes Topical Cannabis to the Next Level with Its Patented Drug Delivery Technology

March 23rd, 2021 - Ryan Allway

Cannabinoids have become some of the most popular health and wellness products in the world. For example, CBD-infused topicals are expected to reach $4.5 billion in sales by 2025, according to Cultivating Wellness, which represents a 540% increase since 2020. At the same time, topicals infused with THC or combinations of CBD and THC are […]

CBD Innovator, HempFusion, Makes Successful Debut on TSX

January 13th, 2021 - Ryan Allway

  HempFusion Wellness Inc. (TSX: CBD-U) shares soared over 65% following their successful debut on the Toronto Stock Exchange (TSX) on Wednesday, January 6, 2021. Cannabidiol, or CBD, has become one of the most popular health and wellness products in the world over the past couple of years. According to Research and Markets, the global […]

Canibrands Capitalizes on CBD with Deep Product Line & Celebrity Support

December 6th, 2019 - Ryan Allway
CaniBrands products

Cannabidiol, better known as CBD, has become one of the most popular wellness products in the United States over the past couple of years. BDS Analytics and Arcview Market Research expect CBD sales to grow at a 49% compound annual growth rate to surpass $20 billion by 2024—making up about half of the total cannabinoid […]

cbdMD Sales Growing, Key Influencers Continue to Bring the Product Mainstream

September 17th, 2019 - Ryan Allway

  CBD, or cannabidiol, has moved into the mainstream, a normalization process that has been supported by several regulatory and legislative events. The framework may be on the government side, but consumer uptake is being accelerated by key influencers promoting brands while educating the public on these events, as well as the potential benefits of […]

XPhyto Therapeutics Ready to Be Cannabis’ Newest Public Entity

August 2nd, 2019 - Ryan Allway

Only days after announcing that its wholly owned subsidiary was awarded a German cannabis and cultivation and extraction licence, XPhyto Therapeutics is ready to enter the public domain. With a final prospectus filed with the British Columbia Securities Commission, XPhyto is ready to go public on the CSE under the ticker “XPHY”. The company will […]

CannabisFN Profile: Recognizable Cannabis Advocate, Steve DeAngelo & Harborside Inc.

July 30th, 2019 - Ryan Allway

There are many celebrities that have been involved in the cannabis industry, but few have been as actively involved in the community as Steve DeAngelo. As a pioneering cannabis entrepreneur, activist, author and on-screen personality, DeAngelo co-founded several iconic cannabis businesses and organizations and continues to play an instrumental role in reforming cannabis laws through […]

Synthetic Cannabinoids: The New Age of Medical Marijuana

July 22nd, 2019 - Ryan Allway

Believe it or not, the world’s first blockbuster drug is still one of the most commonly used today. Acetylsalicylic acid, better known as Aspirin®, is a synthetic derivative of the natural substance salicylic acid, an extract from the bark of the white willow tree. Any company would like to invent a drug that enjoys 100+ […]

Nabis™ Expands National Footprint with California Acquisition

June 18th, 2019 - Ryan Allway

There are many multi-state operators seeking a slice of the $14.5 billion U.S. cannabis industry, but few have the ambition and expertise of Nabis Holdings Inc. (CSE: NAB) (OTC: INNPF) (FRA: 7IP). Staying true to its name, meaning ‘repeat performance’ or ‘encore’, the co-founders behind MPX Bioceuticals Corp. (CSE: MPX), which was purchased by iAnthus […]

Freshly Public, This Company is Building a Global Cannabis Footprint

June 13th, 2019 - Ash Stringer

 Jushi Holdings Inc. (NEO: JUSH) made its public debut on Monday, June 10th.  The Boca Raton-based company has assembled a highly skilled and diversified team that is moving with a purpose, building a global footprint via organic and inorganic growth to capitalize on booming demand for cannabidiol, or CBD, in North America and abroad. According […]

Nabis™ Founders Look to Repeat Success & Build a Leading Cannabis MSO

June 7th, 2019 - Ryan Allway

Nabis Holdings Inc. (CSE: NAB) was founded by two of the four founders of MPX Bioceutical Corp. (CSE: MPX), which was one of the first companies to successfully become a multi-state operator, or MSO, in the United States. In October 2018, MPX was acquired by iAnthus Capital Holdings Inc. (OTCQX: ITHUF) for C$835 million in […]

Why Branding Matters in the Cannabis Industry

April 16th, 2019 - Ryan Allway

The global cannabis industry is projected to reach $146.4 billion by 2025, according to Grand View Research, representing a blistering 34.6 percent compound annual growth rate. While the industry is known for strain names, like OG Kush and Girl Scout Cookies, there aren’t established marquee brands like those found in tobacco or pharmaceutical industries—which has […]

Harvest One Ensures Cannabis Supply with Greenbelt Acquisition

April 9th, 2019 - Ryan Allway

Vertical integration has become kind of a buzzword in the cannabis industry over the last few years. Many companies claim it as a goal, with the intent of controlling the whole supply chain for their products from seed-to-sale. Getting to that level of control can prove difficult, however, as the resources, equipment, and expertise required […]

Why Cannabis Concentrates Are a Big Deal for Investors

March 26th, 2019 - Ryan Allway

The term “concentrate” is widely used across the cannabis industry, but the definition is ambiguous since it encompasses any product procured through an extraction process. While hash and shatter have been staples of the cannabis industry for years, new extraction techniques and upcoming legalization could make concentrates even more important. Cannabis concentrates contain high levels […]

Creso Pharma Secures Canadian License to Cultivate in Nova Scotia

February 27th, 2019 - Ryan Allway

Creso Pharma Inc.(ASX: CPH) is a commercial-stage company that operates in multiple parts of the burgeoning cannabis industry. With an existing line of health and wellness products, the company is actively generating revenue across European markets. The company’s recently granted license to cultivate in Nova Scotia provides additional exposure to Canada’s recreational and medical markets and […]

Beleave Selects 3 Sixty Secure Corp. to Provide Secure Transport Services for Medical and Non-Medical Cannabis Products

February 14th, 2019 - Ryan Allway

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./ ALMONTE, ON, Feb. 14, 2019 /CNW/ – 3 Sixty Risk Solutions Ltd. (“3 Sixty” or the “Company“) (CSE: SAFE) is pleased to announce that the Company, which operates through its wholly-owned subsidiary, 3 Sixty Secure Corp., is providing secure transport […]

Next Green Wave Signs MOU with Organic Medical Growth to Enter the Colombian Medical Cannabis Market

February 14th, 2019 - Ryan Allway

Next Green Wave to take a strategic investment in Organic Medical Growth as the company moves towards a proposed IPO in 2019 Vancouver, British Columbia–(Newsfile Corp. – February 14, 2019) – Next Green Wave Holdings Inc. (CSE: NGW) (OTCQB: NXGWF) (“Next Green Wave” or the “Company”), is pleased to announce that it has entered into […]

FSD Pharma Provides Update on Operations, Strategy and Leadership

February 14th, 2019 - Ryan Allway

TORONTO, Feb. 14, 2019 /CNW/ – FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD”), a licensed producer under the Cannabis Act, today provided a corporate update on operations, strategy and leadership changes. Management Changes On February 6, 2019, the Company announced it had implemented changes in leadership and business practices to optimize operations. Accordingly, the […]

Biome Grow Delivers on Massive Cannabis Supply Contract

February 13th, 2019 - Ryan Allway

Canada’s cannabis industry continues to face supply shortages following adult-use legalization last year. While new licensed producers are coming online every week and established companies are ramping up production, many experts believe that the supply shortage will persist for at least another year or two. These dynamics have created an opportunity for existing producers to […]

Yield Growth Expanding Product Lines & Distribution Footprint

February 11th, 2019 - Ryan Allway

There’s no doubt that the cannabis industry is poised for rapid growth over the coming quarters, but investors have many options in the space. While licensed producers and retailers tend to capture the headlines, investors may want to take a closer look at companies developing innovative products lines in high-growth segments, such as the beverage, […]

Helix TCS: A Clear Market Leader in Cannabis Ancillary Services

February 11th, 2019 - Ryan Allway

The legal cannabis industry (“LCI”) is projected to reach nearly $150 billion in revenue by 2025, according to Grand View Research, driven by the legalization of medical and adult-use cannabis around the world. Despite these rapid growth rates, there’s a significant shortage of support services to help cultivators, wholesalers, processors, and retailers navigate the complex […]

Canna Candys Announces Distribution Deal for a Million Gummies Per Month

February 8th, 2019 - Ryan Allway

Weekend Unlimited Brand Canna Candys to launchin US Northeast, Midwest and Southeast with Initial US $350,000 Order VANCOUVER, BC / ACCESSWIRE / February 8, 2019 / Weekend Unlimited Inc. (“Weekend” or the “Company”) (CSE: POT – FSE: 0OS1 – OTCMKTS: WKULF) announces that its Canna Candy brand has signed an exclusive distribution deal with Infinity […]

Supreme Cannabis Expands Domestic Distribution to Eight Provinces

February 7th, 2019 - Ryan Allway

Supreme Cannabis’ wholly owned subsidiary, 7ACRES, has agreed to supply cannabis to retailers in the provinces of New Brunswick and Saskatchewan. 7ACRES now joins an exclusive group of licensed producers with recreational distribution in eight or more provinces. TORONTO, Feb. 7, 2019 /PRNewswire/ – The Supreme Cannabis Company, Inc. (“Supreme Cannabis” or the “Company”) (TSX: […]

FSD Pharma Signs Collaboration and Profit-Sharing Agreement with Pharmastrip for Production and Delivery of Organic Medical Cannabis Infused in Oral Thin Film Strips

February 7th, 2019 - Ryan Allway

Canada NewsWire TORONTO, Feb. 7, 2019 TORONTO, Feb. 7, 2019 /CNW/ – FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company), a licensed producer under the Cannabis Act, announced today that it has completed a strategic investment of $1.5 million in Pharmastrip Corp. and signed a definitive collaboration and profit sharing […]

CannabisNewsAudio Announces Audio Press Release (APR) on Lexaria Bioscience Corp. Gaining Appeal in Cannabis Edibles with DehydraTECH

February 1st, 2019 - Ryan Allway

NEW YORK, Feb. 01, 2019 (GLOBE NEWSWIRE) — via CannabisNewsWire – CannabisNewsAudio announces the Audio Press Release (APR) titled “Outside Investment, New Technology Support Growing Cannabis Industry,” featuring Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP). To hear the CannabisNewsAudio version, visit: http://cnw.fm/uXf6S To read the full editorial, visit: http://cnw.fm/H3q7r DehydraTECH transforms the situation by seriously reducing […]

The Alkaline Water Company Expands its Packaging Capabilities to Launch New Products

January 31st, 2019 - Ryan Allway

SCOTTSDALE, Ariz., Jan. 31, 2019 (GLOBE NEWSWIRE) — The Alkaline Water Company Inc. (NASDAQ and TSXV: WTER), a leading producer of premium bottled alkaline drinking water sold under the brand name Alkaline88®, today announced that it has expanded an existing relationship with a key co-packaging partner based in Nevada. Specifically, Western Group Packaging (WGP) will begin producing […]

TransCanna Signs LOI To Acquire Goodfellas Group, LLC

January 29th, 2019 - Ryan Allway

Transcanna Holdings Inc. (CSE:TCAN, XETR:TH8) (“TransCanna” or the “Company”) is pleased to announce that it has signed a non-binding Letter of Intent to acquire Goodfellas Group, LLC, (“Goodfellas”) a full service advertising and marketing agency for the cannabis and hemp industries, from which the Company is already acquiring 23 branding agreements. The acquisition price will be […]

Pascal Biosciences Commences Cannabinoid Testing of Human Volunteers and Patients

January 24th, 2019 - Ryan Allway

VANCOUVER, British Columbia, and SEATTLE, Jan. 24, 2019 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced the testing of cannabinoids in human subjects for its immune stimulatory program in cancer. Furthermore, the Company has filed an international patent application to protect this work for […]

Yield Growth: Beyond Cannabis Flower & Edibles

January 24th, 2019 - Ryan Allway

Most investors are familiar with cannabis flower, edibles, and extracts, which have created overnight multi-billion dollar markets around the world. With rising competition in many of these markets, investors may want to turn their attention to lesser known subsets of the cannabis industry, including medical cannabis research and the multi-trillion dollar health and wellness industry […]

YIELD GROWTH Announces listing in Frankfurt (YG3) and Trading Symbol on OTC Markets (OTC:BOSQF)

January 24th, 2019 - Ryan Allway

VANCOUVER, British Columbia, Jan. 24, 2019 (GLOBE NEWSWIRE) — The Yield Growth Corp. (CSE:BOSS) (BOSQF) (Frankfurt:YG3) is pleased to announce that Yield Growth’s common shares have been listed on the Frankfurt Stock Exchange under the trading symbol “YG3”. Yield Growth is also now quoted on OTC Markets under the symbol “BOSQF”. The company’s common shares […]


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading